Literature DB >> 7436445

Sequential study of liver biopsy in thalassaemia.

G Masera, G Jean, V Conter, S Terzoli, R A Mauri, M Cazzaniga.   

Abstract

Liver biopsies were performed in 47 thalassaemic children. 33 of them had laboratory findings that suggested chronic hepatitis; the other 14 patients, without such signs, underwent liver biopsies during splenectomy. Nine patients showed a more or less pronounced fibrosis, 26 showed chronic persistent hepatitis, and 12 had histological evidence of chronic aggressive hepatitis. The last 12 patients who had been treated with corticosteroids, and 9 other patients who showed a worsening of their liver function tests, underwent sequential biopsy. We suggest that chronic liver disease in thalassaemic children can produce inflammatory infiltration even without biochemical or clinical sign of chronic hepatitis, that it can progress towards cirrhosis even in patients with chronic persistent hepatitis, and that there appears to be no benefit in giving corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436445      PMCID: PMC1626895          DOI: 10.1136/adc.55.10.800

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  2 in total

Review 1.  Epidemiology of serum hepatitis.

Authors:  O Ringertz
Journal:  Clin Gastroenterol       Date:  1974-05

2.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

  2 in total
  2 in total

1.  Cirrhosis associated with multiple transfusions in thalassaemia.

Authors:  G Jean; S Terzoli; R Mauri; L Borghetti; A Di Palma; A Piga; M Magliano; M Melevendi; M Cattaneo
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

2.  Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.

Authors:  G A Moroni; G Piacentini; S Terzoli; G Jean; G Masera
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.